1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Middle East Radiotherapy Market Outlook - Forecast (2014-2020)

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance Middle East (Qatar, Saudi Arabia, Kuwait, UAE and Others). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

Middle East Radiotherapy Market Outlook - Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.3.1 Strong Network of the major players
3.3.2 Wide range of product offerings
3.3.3 Increasing usage of Chocolate as a Functional Food
3.4 Market Constraints
3.4.1 Supply Dependency On West African Countries For Cocoa
3.4.2 Sluggish growth in Developed regions
3.4.3 Rapidly changing end user preferences

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Radiotherapy Market by Product Type
5.1 Non-Ionizing Radiation
5.2 Ionizing Radiation
5.3 Particle Radiation
5.4 Electron Beams
5.5 Proton Beams
5.6 Neutron Beams
5.7 Carbon Ions
5.8 Alpha and Beta Particles
5.9 Photon Radiations
5.10 Gamma Rays
5.11 X-rays

6 Radiotherapy Market by Technology
6.1 Intensity Modulated Radiation Therapy (IMRT)
6.2 3-D Conformal Radiotherapy (3D CRT)
6.3 Proton Beam Therapy
6.4 Stereotactic Technology
6.5 Tomotherapy
6.6 Adaptive Radiation Therapy
6.7 Systemic Radiation Therapy

7 Radiotherapy Market by Application
7.1 Lung Cancer
7.2 Colorectal Cancer
7.3 Prostate Cancer
7.4 Breast Cancer
7.5 Head and Neck Cancer
7.6 Brain Cancer
7.7 Spine Cancer
7.8 Cervical Cancer

8 Geographical Segmentation
8.1 Middle East
8.1.1 Qatar
8.1.2 Saudi Arabia
8.1.3 Kuwait
8.1.4 UAE
8.1.5 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Varian Medical Systems
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Siemens Healthcare
10.3 Nordion, Inc
10.4 IBA Group
10.5 GE Healthcare
10.6 Covidien, Plc
10.7 Cardinal Health, Inc.
10.8 Accuray, Inc.
10.9 ANSTO
10.10 C. R. Bard, Inc.
11 Appendix
12 Disclaimer

List of Exhibits
Table 1 Middle East Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 2 Middle East Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 3 Middle East Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 4 Middle East Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 5 Middle East Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 6 Middle East Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 7 Middle East Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 8 Middle East Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 9 Middle East Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 10 Middle East Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 11 Middle East Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 12 Middle East Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 13 Middle East Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 14 Middle East Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 15 Middle East Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 16 Middle East Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 17 Middle East Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 18 Middle East Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 19 Middle East Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 20 Middle East Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 21 Middle East Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 22 Middle East Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 23 Middle East Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 24 Middle East Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 25 Middle East Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 26 Middle East Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 27 Middle East Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 28 Middle East Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 29 Middle East Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 30 Middle East Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 31 Qatar Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 32 Qatar Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 33 Qatar Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 34 Qatar Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 35 Qatar Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 36 Qatar Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 37 Qatar Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 38 Qatar Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 39 Qatar Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 40 Qatar Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 41 Qatar Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 42 Qatar Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 43 Qatar Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 44 Qatar Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 45 Qatar Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 46 Qatar Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 47 Qatar Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 48 Qatar Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 49 Qatar Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 50 Qatar Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 51 Qatar Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 52 Qatar Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 53 Qatar Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 54 Qatar Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 55 Qatar Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 56 Qatar Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 57 Qatar Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 58 Qatar Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 59 Qatar Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 60 Qatar Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 61 Saudi Arabia Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 62 Saudi Arabia Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 63 Saudi Arabia Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 64 Saudi Arabia Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 65 Saudi Arabia Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 66 Saudi Arabia Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 67 Saudi Arabia Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 68 Saudi Arabia Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 69 Saudi Arabia Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 70 Saudi Arabia Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 71 Saudi Arabia Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 72 Saudi Arabia Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 73 Saudi Arabia Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 74 Saudi Arabia Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 75 Saudi Arabia Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 76 Saudi Arabia Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 77 Saudi Arabia Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 78 Saudi Arabia Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 79 Saudi Arabia Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 80 Saudi Arabia Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 81 Saudi Arabia Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 82 Saudi Arabia Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 83 Saudi Arabia Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 84 Saudi Arabia Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 85 Saudi Arabia Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 86 Saudi Arabia Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 87 Saudi Arabia Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 88 Saudi Arabia Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 89 Saudi Arabia Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 90 Saudi Arabia Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 91 Kuwait Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 92 Kuwait Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 93 Kuwait Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 94 Kuwait Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 95 Kuwait Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 96 Kuwait Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 97 Kuwait Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 98 Kuwait Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 99 Kuwait Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 100 Kuwait Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 101 Kuwait Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 102 Kuwait Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 103 Kuwait Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 104 Kuwait Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 105 Kuwait Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 106 Kuwait Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 107 Kuwait Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 108 Kuwait Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 109 Kuwait Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 110 Kuwait Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 111 Kuwait Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 112 Kuwait Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 113 Kuwait Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 114 Kuwait Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 115 Kuwait Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 116 Kuwait Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 117 Kuwait Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 118 Kuwait Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 119 Kuwait Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 120 Kuwait Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 121 UAE Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 122 UAE Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 123 UAE Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 124 UAE Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 125 UAE Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 126 UAE Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 127 UAE Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 128 UAE Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 129 UAE Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 130 UAE Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 131 UAE Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 132 UAE Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 133 UAE Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 134 UAE Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 135 UAE Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 136 UAE Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 137 UAE Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 138 UAE Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 139 UAE Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 140 UAE Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 141 UAE Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 142 UAE Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 143 UAE Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 144 UAE Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 145 UAE Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 146 UAE Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 147 UAE Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 148 UAE Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 149 UAE Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 150 UAE Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.